Group of Molecular and Cellular Biology of Parkinson's disease
Parkinson neurobiol
Max Planck Institute for Experimental Medicine
Gotinga, AlemaniaPublications in collaboration with researchers from Max Planck Institute for Experimental Medicine (11)
2024
2022
-
Endogenous Levels of Alpha-Synuclein Modulate Seeding and Aggregation in Cultured Cells
Molecular Neurobiology, Vol. 59, Núm. 2, pp. 1273-1284
2021
-
Doxycycline Interferes With Tau Aggregation and Reduces Its Neuronal Toxicity
Frontiers in Aging Neuroscience, Vol. 13
-
Doxycycline inhibits α-synuclein-associated pathologies in vitro and in vivo
Neurobiology of Disease, Vol. 151
2020
-
Effects of pharmacological modulators of α-synuclein and tau aggregation and internalization
Scientific Reports, Vol. 10, Núm. 1
-
Pharmacological modulators of tau aggregation and spreading
Brain Sciences, Vol. 10, Núm. 11, pp. 1-29
-
Synucleinopathies: Where we are and where we need to go
Journal of Neurochemistry, Vol. 153, Núm. 4, pp. 433-454
2019
-
Cytosolic Trapping of a Mitochondrial Heat Shock Protein Is an Early Pathological Event in Synucleinopathies
Cell Reports, Vol. 28, Núm. 1, pp. 65-77.e6
-
LRRK2, alpha-synuclein, and tau: Partners in crime or unfortunate bystanders?
Biochemical Society Transactions, Vol. 47, Núm. 3, pp. 827-838
-
Spreading of α-synuclein and tau: A systematic comparison of the mechanisms involved
Frontiers in Molecular Neuroscience, Vol. 12
-
Synthesis and evaluation of esterified Hsp70 agonists in cellular models of protein aggregation and folding
Bioorganic and Medicinal Chemistry, Vol. 27, Núm. 1, pp. 79-91